Sybron Dental Specialties, Inc. Acquires Oraltronics Dental Implant Technology GmbH

Sybron Dental Specialties, Inc. Acquires Oraltronics Dental
Implant Technology GmbH 


ORANGE, Calif., June 8  /PRNewswire-FirstCall/ -- Sybron Dental Specialties,
Inc. (NYSE:SYD), a leading manufacturer of a broad range of value-added
products for the dental profession including the specialty markets of
endodontics, implantology, and orthodontics, announced today that its
subsidiary Ormco B.V. acquired all of the outstanding stock of Oraltronics
Dental Implant Technology GmbH ("Oraltronics"), a privately held company
headquartered in Bremen, Germany engaged in the manufacture and sale of dental
implants.  Established in 1979, by Professor Hans L. Grafelmann, Oraltronics
generated annual revenues of approximately $10 million in 2004.  The purchase
of the company was made using Sybron Dental Specialties' existing cash.  The
Company expects the acquisition to be accretive within the first year of
operations.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20001204/SDSLOGO)

"Oraltronics represents an ideal addition to our subsidiary Innova
Lifesciences, which we acquired last October as a means of entering the rapidly
growing dental implant market," said Floyd W. Pickrell, Jr., Chief Executive
Officer of Sybron Dental Specialties.  "Oraltronics not only increases our
scale in this exciting segment of dentistry, it also provides a strong presence
in several key countries in Europe that will serve as an excellent platform to
promote the sale of Innova's press fit implant design in Europe.  In addition,
we believe the addition of Oraltronics' patented implant design will have a
positive impact on Innova's sales in the United States and Canada."

Oraltronics will be managed by the Company's Innova subsidiary, which continues
to be led by Innova's founder and President, Mr. Michael Kehoe.  "We are very
pleased to add the highly regarded Oraltronics implants to the Innova product
line," said Mr. Kehoe.  "Their threaded implant design offers an excellent
complement to our Endopore product and we look forward to the opportunities
that this acquisition offers to drive the worldwide sales of both the
Oraltronics and Innova brands via a strengthened sales and distribution
network."

CAUTION REGARDING FORWARD-LOOKING STATEMENTS

Statements made in this press release regarding future matters are
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995.  Forward-looking statements, including those
dealing with the Company's expectations as to its future revenue, earnings per
share, the demand for its products, the benefits of the Oraltronics
acquisition, and the ability of the Innova sales force to sell Oraltronics'
products are based on the Company's current expectations.  Our actual results
may differ materially from those currently expected or desired because of a
number of risks and uncertainties, including the level of demand for the
Company's products; the ability to obtain regulatory approval to sell the
Oraltronics products in the United States and Canada; currency fluctuations;
the intensity of competition; and other factors affecting the Company's
business and prospects discussed in the filings made by the Company, from time
to time, with the SEC including the factors discussed in the "Cautionary
Factors" section in Item 7 of the Company's most recent Annual Report on Form
10-K and its periodic reports on Form 10-Q and 8-K (if any).  We undertake no
obligation to publicly update any forward-looking statement, whether as a
result of new information, future events or otherwise. 

http://www.newscom.com/cgi-bin/prnh/20001204/SDSLOGO

http://photoarchive.ap.org/

DATASOURCE: Sybron Dental Specialties, Inc.



CONTACT:  Bernard J. Pitz, Chief Financial Officer of Sybron Dental

Specialties, Inc., [phone]

Copyright